WeVote
Log In

Bill

Bill

A 5830

Requires health insurers to provide coverage for diagnosis and treatment of fibroids

2025 Regular Session Introduced by Harvey Epstein and 2 co-sponsors

Bill A 5830 mandates health insurers to cover diagnosis and treatment of uterine fibroids, improving access to care for affected patients without high costs.

REFERRED TO INSURANCE
0
WeVote Research Nonpartisan
Bill Summary · A 5830

Summary of Bill A 5830

Bill Information

  • Bill Number: A 5830
  • Title: Requires health insurers to provide coverage for diagnosis and treatment of fibroids
  • Status: Referred to Insurance
  • Introduced: February 20, 2025
  • Classification: Bill

Purpose and Intent

Bill A 5830 aims to ensure that health insurance providers are mandated to cover the diagnosis and treatment of uterine fibroids. Uterine fibroids are non-cancerous growths in the uterus that can cause significant health issues, including pain, heavy menstrual bleeding, and complications during pregnancy. By requiring coverage for these conditions, the bill seeks to improve access to necessary medical care for individuals affected by fibroids.

Key Provisions

  • Coverage Requirement: The bill mandates that all health insurers provide comprehensive coverage for:

    • Diagnosis of uterine fibroids, including necessary imaging and laboratory tests.
    • Treatment options for fibroids, which may include medication, minimally invasive procedures, and surgical interventions.

  • Patient Education: Insurers are encouraged to provide educational resources to patients regarding the nature of fibroids, treatment options, and potential outcomes.

  • Exclusions: The bill specifies that coverage must not be denied based on the size or number of fibroids, ensuring that all patients receive equitable treatment regardless of their specific condition.

Who Would Be Affected

  • Patients: Individuals diagnosed with uterine fibroids will benefit from improved access to necessary medical services without the burden of high out-of-pocket costs.
  • Health Insurers: Insurance companies will need to adjust their policies and coverage plans to comply with the new requirements set forth by the bill.
  • Healthcare Providers: Medical professionals will have clearer guidelines on what treatments are covered, potentially leading to better patient outcomes.

Procedural Aspects

  • Current Status: As of February 20, 2025, the bill has been referred to the Insurance Committee for further consideration.
  • Related Legislation: The bill is related to previous legislative efforts, including:
    • A 9054 (prior-session)
    • A 2058 (prior-session)
    • S 2397 (companion bill in the Senate)

Conclusion

Bill A 5830 represents a significant step towards improving healthcare access for individuals suffering from uterine fibroids. By mandating insurance coverage for diagnosis and treatment, the bill aims to alleviate the financial burden on patients and ensure they receive timely and appropriate care. The bill is currently under review by the Insurance Committee, and its progress will be closely monitored by stakeholders in the healthcare community.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.